{"id":"https://openalex.org/W4295898144","doi":"https://doi.org/10.1002/phar.2728","title":"Time to defervescence evaluation for extended\u2010 vs. standard\u2010infusion cefepime in patients with acute leukemia and febrile neutropenia","display_name":"Time to defervescence evaluation for extended\u2010 vs. standard\u2010infusion cefepime in patients with acute leukemia and febrile neutropenia","publication_year":2022,"publication_date":"2022-09-15","ids":{"openalex":"https://openalex.org/W4295898144","doi":"https://doi.org/10.1002/phar.2728","pmid":"https://pubmed.ncbi.nlm.nih.gov/36106434"},"language":"en","primary_location":{"id":"doi:10.1002/phar.2728","doi":"https://doi.org/10.1002/phar.2728","is_oa":false,"landing_page_url":"https://doi.org/10.1002/phar.2728","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Robert Crawford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802152183","display_name":"Novant Health","ror":"https://ror.org/04nv2wh79","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I4210158401","display_name":"Novant Health Forsyth Medical Center","ror":"https://ror.org/04mm17p39","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802152183","https://openalex.org/I4210158401"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Crawford","raw_affiliation_strings":["Department of Pharmacy, Novant Health, Winston-Salem, North Carolina, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Novant Health, Winston-Salem, North Carolina, USA","institution_ids":["https://openalex.org/I2802152183","https://openalex.org/I4210158401"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088008458","display_name":"Nicholson B. Perkins","orcid":"https://orcid.org/0000-0002-3650-3959","observed_orcids":["https://orcid.org/0000-0002-3650-3959"]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]},{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholson B. Perkins","raw_affiliation_strings":["Department of Pharmacy, Henry Ford Hospital, Detroit, Michigan, USA"],"raw_orcid":"https://orcid.org/0000-0002-3650-3959","affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Henry Ford Hospital, Detroit, Michigan, USA","institution_ids":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071806329","display_name":"Diana A. Hobbs","orcid":"https://orcid.org/0000-0001-7822-6411","observed_orcids":["https://orcid.org/0000-0001-7822-6411"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana A. Hobbs","raw_affiliation_strings":["Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology, Washington University School of Medicine, St. Louis, Missouri, USA","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045043665","display_name":"Athena L V Hobbs","orcid":"https://orcid.org/0000-0002-2109-6123","observed_orcids":["https://orcid.org/0000-0002-2109-6123"]},"institutions":[{"id":"https://openalex.org/I4210150323","display_name":"Cardinal Health (United States)","ror":"https://ror.org/03pd82777","country_code":"US","type":"company","lineage":["https://openalex.org/I4210150323"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Athena L. V. Hobbs","raw_affiliation_strings":["Clinical Manager- Infectious Diseases, Cardinal Health Innovative Delivery Solutions, Dublin, Ohio, USA"],"raw_orcid":"https://orcid.org/0000-0002-2109-6123","affiliations":[{"raw_affiliation_string":"Clinical Manager- Infectious Diseases, Cardinal Health Innovative Delivery Solutions, Dublin, Ohio, USA","institution_ids":["https://openalex.org/I4210150323"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5045043665"],"corresponding_institution_ids":["https://openalex.org/I4210150323"],"apc_list":{"value":3550,"currency":"USD","value_usd":3550},"apc_paid":null,"fwci":0.8974,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.72108773,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"42","issue":"10","first_page":"798","last_page":"805"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cefepime","display_name":"cefepime","score":0.9089999794960022},{"id":"https://openalex.org/keywords/prolonged-infusion","display_name":"prolonged infusion","score":0.9409999847412109},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.9850000143051147},{"id":"https://openalex.org/keywords/acute-leukemia","display_name":"acute leukemia","score":0.9890000224113464},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8579999804496765},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9319999814033508},{"id":"https://openalex.org/keywords/time-to-defervescence","display_name":"time to defervescence","score":0.9129999876022339},{"id":"https://openalex.org/keywords/beta-lactam-antibiotics","display_name":"beta-lactam antibiotics","score":0.9300000071525574},{"id":"https://openalex.org/keywords/antibiotic-dosing-regimens","display_name":"antibiotic dosing regimens","score":0.5809999704360962},{"id":"https://openalex.org/keywords/30-day-mortality","display_name":"30-day mortality","score":0.7020000219345093},{"id":"https://openalex.org/keywords/length-of-hospital-stay","display_name":"length of hospital stay","score":0.7870000004768372},{"id":"https://openalex.org/keywords/antibiotic-escalation","display_name":"antibiotic escalation","score":0.4569999873638153}],"concepts":[{"id":"https://openalex.org/C2777050379","wikidata":"https://www.wikidata.org/wiki/Q2552927","display_name":"Cefepime","level":5,"score":0.9916485548019409},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8378404378890991},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.8179216980934143},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5995680093765259},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.582284152507782},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.524985671043396},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.43992850184440613},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3361310064792633},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.27665311098098755},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.2415856420993805},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C94665300","wikidata":"https://www.wikidata.org/wiki/Q63391344","display_name":"Antibiotic resistance","level":3,"score":0.0},{"id":"https://openalex.org/C2779631663","wikidata":"https://www.wikidata.org/wiki/Q425152","display_name":"Imipenem","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000077723","descriptor_name":"Cefepime","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D047090","descriptor_name":"beta-Lactams","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D064147","descriptor_name":"Febrile Neutropenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/phar.2728","doi":"https://doi.org/10.1002/phar.2728","is_oa":false,"landing_page_url":"https://doi.org/10.1002/phar.2728","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},{"id":"pmid:36106434","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36106434","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1972377682","https://openalex.org/W1996635339","https://openalex.org/W1999130958","https://openalex.org/W2026274122","https://openalex.org/W2037346760","https://openalex.org/W2066745723","https://openalex.org/W2076363688","https://openalex.org/W2106307190","https://openalex.org/W2109836588","https://openalex.org/W2123859227","https://openalex.org/W2139037525","https://openalex.org/W2149258023","https://openalex.org/W2168210585","https://openalex.org/W2179850291","https://openalex.org/W2526778605","https://openalex.org/W2573333828","https://openalex.org/W2576933161","https://openalex.org/W2794717835","https://openalex.org/W2902532896","https://openalex.org/W2989089762","https://openalex.org/W3028278848"],"related_works":["https://openalex.org/W2573333828","https://openalex.org/W2793160760","https://openalex.org/W4389029770","https://openalex.org/W4410804183","https://openalex.org/W4389031362","https://openalex.org/W2981884303","https://openalex.org/W4213365051","https://openalex.org/W2899569643","https://openalex.org/W4403564985","https://openalex.org/W3018813296"],"abstract_inverted_index":{"BACKGROUND/OBJECTIVES:":[0],"Febrile":[1],"neutropenia":[2],"(FN)":[3],"occurs":[4],"in":[5,25,73,113,217],"up":[6],"to":[7,81,122,126,171,187],"80%":[8],"of":[9,20,131,140,163,167,212,254],"patients":[10,57,85,177],"with":[11,58,86,96,192,195,221],"hematologic":[12],"malignancies.":[13],"Evidence":[14],"suggests":[15],"using":[16],"extended":[17],"infusions":[18],"(EI)":[19],"beta-lactams":[21],"can":[22],"improve":[23],"outcomes":[24,83,156,241],"some":[26],"populations,":[27],"but":[28],"there":[29],"is":[30],"limited":[31],"clinical":[32],"literature":[33],"comparing":[34],"cefepime":[35,72,132,142,151,257],"standard":[36],"infusion":[37],"(SI)":[38],"versus":[39],"EI":[40,63,71,92,135,147,193,219,256],"for":[41,46,56,70,272],"FN.":[42],"The":[43,118],"FDA-approved":[44,281],"regimen":[45,283],"FN":[47,59,74,87,104,273],"was":[48,66,121,189,214,235],"used":[49],"at":[50,75],"a":[51,61,260],"large":[52],"community":[53],"teaching":[54],"hospital":[55,161],"until":[60],"hospital-wide":[62],"beta-lactam":[64],"protocol":[65],"introduced":[67],"that":[68],"allowed":[69],"the":[76,129,196,218,222,280],"physicians'":[77],"discretion.":[78],"We":[79],"sought":[80],"compare":[82,123],"between":[84,105,184,238],"who":[88,102],"received":[89],"SI":[90,133,137,197,223,282],"and":[91,108,146,169,245,284],"cefepime.":[93],"METHODS:":[94],"Patients":[95],"acute":[97],"myeloid":[98],"or":[99,134],"lymphocytic":[100],"leukemia":[101],"developed":[103],"April":[106],"2014":[107],"January":[109],"2021":[110],"were":[111,178,182],"included":[112,157],"this":[114],"single-center,":[115],"retrospective":[116],"study.":[117],"primary":[119],"outcome":[120],"mean":[124],"time":[125],"defervescence":[127,188,278],"after":[128],"initiation":[130],"regimens.":[136],"regimens":[138,148],"consisted":[139],"IV":[141,150],"2G":[143],"q8h/0.5":[144],"h,":[145],"as":[149,259],"1G":[152,269],"q8h/4":[153,270],"h.":[154],"Secondary":[155],"30-day":[158],"all-cause":[159],"mortality,":[160,244],"length":[162],"stay":[164],"(LOS),":[165],"duration":[166,211],"cefepime,":[168,255],"need":[170],"escalate":[172],"therapy.":[173],"RESULTS:":[174],"Overall,":[175],"193":[176],"included.":[179],"Baseline":[180],"characteristics":[181],"similar":[183],"groups.":[185],"Time":[186],"significantly":[190,215],"shorter":[191,216],"compared":[194,220],"group":[198,224],"(median":[199,225],"48":[200],"h":[201,205,262,266,271],"[48-100.5]":[202],"vs.":[203,228],"70":[204],"[48-113],":[206],"p":[207,231],"=":[208,232],"0.005).":[209],"Cefepime":[210],"therapy":[213],"6.0":[226],"days":[227],"8.0":[229],"days,":[230],"0.002).":[233],"There":[234],"no":[236],"difference":[237],"other":[239],"secondary":[240],"including":[242],"LOS,":[243],"antibiotic":[246],"escalation.":[247],"CONCLUSION:":[248],"Despite":[249],"reduced":[250],"total":[251],"daily":[252],"dose":[253],"administered":[258],"1G/0.5":[261],"LD":[263],"followed":[264],"2":[265],"later":[267],"by":[268],"acutely":[274],"achieves":[275],"more":[276],"rapid":[277],"than":[279],"ultimately":[285],"attains":[286],"comparable":[287],"patient":[288],"outcomes.":[289]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-09-16T00:00:00"}